sub:assertion {
d:DB00277 dv:ddi-interactor-in dr:DB00277_DB04854 .
d:DB04854 dv:ddi-interactor-in dr:DB00277_DB04854 .
dr:DB00277_DB04854 dct:identifier "drugbank_resource:DB00277_DB04854" ;
dct:title "DDI between Theophylline and Febuxostat - Coadministration of febuxostat with xanthine oxidase substrate drugs (azathioprine, mercaptopurine or theophylline) could increase plasma concentrations of these drugs, since these drugs are metabolized by xanthine oxidase, resulting in severe toxicity; hence their concomitant use is contraindicated. Since febuxostat does not inhibit or induce cytochrome P450 enzymes it lacks significant drug interactions with other drugs metabolized of these enzymes."@en ;
a dv:Drug-Drug-Interaction ;
rdfs:label "DDI between Theophylline and Febuxostat - Coadministration of febuxostat with xanthine oxidase substrate drugs (azathioprine, mercaptopurine or theophylline) could increase plasma concentrations of these drugs, since these drugs are metabolized by xanthine oxidase, resulting in severe toxicity; hence their concomitant use is contraindicated. Since febuxostat does not inhibit or induce cytochrome P450 enzymes it lacks significant drug interactions with other drugs metabolized of these enzymes. [drugbank_resource:DB00277_DB04854]"@en .
}